Mirecule Inc
miRecule Inc. is a biotechnology company based in Rockville, MD, focused on developing targeted RNA therapies for cancer and muscular dystrophy. Utilizing their proprietary DREAmiR platform, they harness genomic patient data to create personalized therapeutics aimed at alleviating the debilitating symptoms of these disorders.
In collaboration with industry leaders like Sanofi, miRecule is advancing innovative approaches in rare diseases, particularly facioscapulohumeral muscular dystrophy (FSHD). Their commitment to pioneering antibody-RNA conjugate therapies positions them at the forefront of biopharmaceutical advancements in rare genetic conditions.
Generated from the website
Also at this address
Partial Data by Infogroup (c) 2025. All rights reserved.
